Accessibility: Skip TopNav
James C. Mullen
Editas Medicine announces the appointment of James C. Mullen as Chief Executive Officer, effective February 15, 2021.
Format
JPEG
Source
Editas Medicine, Inc.
Downloads
Original
Large
Medium
Small